D
Aktis Oncology, Inc. AKTS
$25.00 $0.281.13% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025
Total Cash And Short-Term Investments -- 81.21% -23.68%
Total Receivables -- -- 0.00%
Inventory -- -- --
Prepaid Expenses -- -- -6.27%
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- --
Total Current Assets -- -- -23.45%

Total Current Assets -- -- -23.45%
Net Property, Plant & Equipment -- -- 30.54%
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- -- 64.44%
Total Assets -- -- -18.79%

Total Accounts Payable -- -- -9.44%
Total Accrued Expenses -- -- 50.40%
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- 1.47%
Total Finance Division Other Current Liabilities -- -- 101.16%
Total Other Current Liabilities -- -- 101.16%
Total Current Liabilities -- -- 65.95%

Total Current Liabilities -- -- 65.95%
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases -- -- -4.49%
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- -- -29.16%
Total Liabilities -- -- -3.66%

Common Stock & APIC -- -- 111.43%
Retained Earnings -- -- -68.65%
Treasury Stock & Other -- -- -66.13%
Total Common Equity -- 676.41% -66.45%

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- 0.00%
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- 0.00%

Total Common Equity -- 676.41% -66.45%
Total Preferred Equity -- -- 0.00%
Total Minority Interest -- -- --
Total Equity -- 106.06% -23.76%